1. Home
  2. ADN vs BGLC Comparison

ADN vs BGLC Comparison

Compare ADN & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADN
  • BGLC
  • Stock Information
  • Founded
  • ADN 2006
  • BGLC 2017
  • Country
  • ADN United States
  • BGLC Malaysia
  • Employees
  • ADN N/A
  • BGLC N/A
  • Industry
  • ADN Power Generation
  • BGLC Medical Specialities
  • Sector
  • ADN Utilities
  • BGLC Health Care
  • Exchange
  • ADN Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • ADN 8.5M
  • BGLC 7.6M
  • IPO Year
  • ADN N/A
  • BGLC N/A
  • Fundamental
  • Price
  • ADN $1.82
  • BGLC $0.37
  • Analyst Decision
  • ADN
  • BGLC
  • Analyst Count
  • ADN 0
  • BGLC 0
  • Target Price
  • ADN N/A
  • BGLC N/A
  • AVG Volume (30 Days)
  • ADN 28.4K
  • BGLC 117.9K
  • Earning Date
  • ADN 10-15-2024
  • BGLC 11-20-2024
  • Dividend Yield
  • ADN N/A
  • BGLC N/A
  • EPS Growth
  • ADN N/A
  • BGLC N/A
  • EPS
  • ADN N/A
  • BGLC N/A
  • Revenue
  • ADN $7,026,000.00
  • BGLC $9,183,168.00
  • Revenue This Year
  • ADN $2,232.99
  • BGLC N/A
  • Revenue Next Year
  • ADN $91.56
  • BGLC N/A
  • P/E Ratio
  • ADN N/A
  • BGLC N/A
  • Revenue Growth
  • ADN 9.01
  • BGLC N/A
  • 52 Week Low
  • ADN $1.71
  • BGLC $0.31
  • 52 Week High
  • ADN $18.90
  • BGLC $3.39
  • Technical
  • Relative Strength Index (RSI)
  • ADN 41.18
  • BGLC 32.80
  • Support Level
  • ADN $1.79
  • BGLC $0.38
  • Resistance Level
  • ADN $2.17
  • BGLC $0.49
  • Average True Range (ATR)
  • ADN 0.16
  • BGLC 0.02
  • MACD
  • ADN 0.02
  • BGLC -0.01
  • Stochastic Oscillator
  • ADN 23.91
  • BGLC 5.94

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Share on Social Networks: